Liangliang Dai

机构：Jiangsu University, China Pharmaceutical University, Northwestern Polytechnical University, Xuzhou Medical College, Changzhou No.2 People's Hospital, Changzhou University · ORCID：0000-0002-2041-9357

发表论文 85 篇 · 总被引 3905 次 · h-index 36

代表论文

• Multifunctional injectable hydrogel with self-supplied H2S release and bacterial inhibition for the wound healing with enhanced macrophages polarization via interfering with PI3K/Akt pathway (2025 · Biomaterials · 被引 40)
• The Bioactive Interface of Titanium Implant with Both Anti‐Oxidative Stress and Immunomodulatory Properties for Enhancing Osseointegration under Diabetic Condition (2024 · Advanced Healthcare Materials · 被引 19)
• Probiotic Membrane-Modified Nanocomposite Alleviates Inflammation and Microbiota Dysbiosis in Colitis by Scavenging Oxidative Stress and Restoring Immune Homeostasis (2025 · ACS Applied Materials & Interfaces · 被引 15)
• Posttranslational remodeling micelle reverses cell-surface and exosomal PD-L1 immunosuppression in tumors resistant to PD-L1 antibody therapy (2025 · Journal of Controlled Release · 被引 10)
• Carrier‐Free Self‐Assembled Nanoparticles for Triple‐Amplified Tumor Chemodynamic Therapy and Cuproptosis Induction (2025 · Advanced Healthcare Materials · 被引 6)
• Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting (2025 · 中国科学通报：英文版 · 被引 5)